Lv1
40 积分 2025-07-30 加入
Global Landscape of Radiopharmaceutical Innovation: Emerging Targets and Molecules
23小时前
已完结
The pH perspective of cancer: From warburg's misconception to therapeutic targeting of pH regulating proteins
11天前
已完结
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma
25天前
已完结
MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway
3个月前
已完结
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors
3个月前
已完结
Improving Theranostic Gallium-68/Lutetium-177-Labeled PSMA Inhibitors with an Albumin Binder for Prostate Cancer
3个月前
已完结
89Zr/177Lu-Labeled Claudin-6 Antibody Exhibits Effective Targeted Radiodiagnostic and Therapeutic Efficacy in Gynecological Cancers
3个月前
已完结
CD70-Targeted Radiotheranostics: Now and Future
4个月前
已完结
Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics
5个月前
已关闭
A Multicenter Phase II Randomized Controlled Trial Comparing 177Lu-Dotatate/Capecitabine Combination Treatment with 177Lu-Dotatate Monotherapy in Patients with Neuroendocrine Tumors
7个月前
已完结
皖公网安备34019202002308
